These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25564966)

  • 1. Toward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS data.
    Lindh M; Svensson F; Schaal W; Zhang J; Sköld C; Brandt P; Karlén A
    J Chem Inf Model; 2015 Feb; 55(2):343-53. PubMed ID: 25564966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands.
    Lagarde N; Zagury JF; Montes M
    J Chem Inf Model; 2014 Oct; 54(10):2915-44. PubMed ID: 25250508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
    Butkiewicz M; Lowe EW; Mueller R; Mendenhall JL; Teixeira PL; Weaver CD; Meiler J
    Molecules; 2013 Jan; 18(1):735-56. PubMed ID: 23299552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmarking Data Sets from PubChem BioAssay Data: Current Scenario and Room for Improvement.
    Tran-Nguyen VK; Rognan D
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing.
    Riniker S; Fechner N; Landrum GA
    J Chem Inf Model; 2013 Nov; 53(11):2829-36. PubMed ID: 24171408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
    Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
    J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REPROVIS-DB: a benchmark system for ligand-based virtual screening derived from reproducible prospective applications.
    Ripphausen P; Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Oct; 51(10):2467-73. PubMed ID: 21902278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening.
    Tran-Nguyen VK; Jacquemard C; Rognan D
    J Chem Inf Model; 2020 Sep; 60(9):4263-4273. PubMed ID: 32282202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioturbo similarity searching: combining chemical and biological similarity to discover structurally diverse bioactive molecules.
    Wassermann AM; Lounkine E; Glick M
    J Chem Inf Model; 2013 Mar; 53(3):692-703. PubMed ID: 23461561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical comparison of virtual screening methods against the MUV data set.
    Tiikkainen P; Markt P; Wolber G; Kirchmair J; Distinto S; Poso A; Kallioniemi O
    J Chem Inf Model; 2009 Oct; 49(10):2168-78. PubMed ID: 19799417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benchmarking Data Sets for the Evaluation of Virtual Ligand Screening Methods: Review and Perspectives.
    Lagarde N; Zagury JF; Montes M
    J Chem Inf Model; 2015 Jul; 55(7):1297-307. PubMed ID: 26038804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual decoy sets for molecular docking benchmarks.
    Wallach I; Lilien R
    J Chem Inf Model; 2011 Feb; 51(2):196-202. PubMed ID: 21207928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs.
    Xia J; Jin H; Liu Z; Zhang L; Wang XS
    J Chem Inf Model; 2014 May; 54(5):1433-50. PubMed ID: 24749745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.
    Xia J; Tilahun EL; Kebede EH; Reid TE; Zhang L; Wang XS
    J Chem Inf Model; 2015 Feb; 55(2):374-88. PubMed ID: 25633490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening data fusion using both structure- and ligand-based methods.
    Svensson F; Karlén A; Sköld C
    J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of topological, shape, and docking methods in virtual screening.
    McGaughey GB; Sheridan RP; Bayly CI; Culberson JC; Kreatsoulas C; Lindsley S; Maiorov V; Truchon JF; Cornell WD
    J Chem Inf Model; 2007; 47(4):1504-19. PubMed ID: 17591764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.